Dual field effects in electrolyte-gated spinel ferrite: electrostatic carrier doping and redox reactions

por Ichimura, Takashi, Fujiwara, Kohei, Tanaka, Hidekazu
Publicado 2014

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab

por Ushida, Yuta, Shinozaki, Eiji, Chin, Keisho, Suenaga, Mitsukuni, Takahari, Daisuke, Ozaka, Masato, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Yamaguchi, Kensei
Publicado 2018

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer

por Osumi, Hiroki, Shinozaki, Eiji, Takeda, Yoshinori, Wakatsuki, Takeru, Ichimura, Takashi, Saiura, Akio, Yamaguchi, Kensei, Takahashi, Shunji, Noda, Tetsuo, Zembutsu, Hitoshi
Publicado 2018

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

por Nakayama, Izuma, Shinozaki, Eiji, Matsushima, Tomohiro, Wakatsuki, Takeru, Ogura, Mariko, Ichimura, Takashi, Ozaka, Masato, Takahari, Daisuke, Suenaga, Mitsukuni, Chin, Keisho, Mizunuma, Nobuyuki, Yamaguchi, Kensei
Publicado 2017

Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer

por Nakayama, Izuma, Chin, Keisho, Takahari, Daisuke, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Osumi, Hiroki, Ota, Yumiko, Suzuki, Takeshi, Suenaga, Mitsukuni, Shinozaki, Eiji, Yamaguchi, Kensei
Publicado 2018

Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel

por Fukuda, Naoki, Takahari, Daisuke, Wakatsuki, Takeru, Osumi, Hiroki, Nakayama, Izuma, Matsushima, Tomohiro, Ichimura, Takashi, Ogura, Mariko, Ozaka, Masato, Suenaga, Mitsukuni, Shinozaki, Eiji, Chin, Keisho, Yamaguchi, Kensei
Publicado 2018

Phase II trial of biweekly cetuximab and irinotecan as third‐line therapy for pretreated KRAS exon 2 wild‐type colorectal cancer

por Osumi, Hiroki, Shinozaki, Eiji, Mashima, Tetsuo, Wakatsuki, Takeru, Suenaga, Mitsukuni, Ichimura, Takashi, Ogura, Mariko, Ota, Yumiko, Nakayama, Izuma, Takahari, Daisuke, Chin, Keisho, Miki, Yoshio, Yamaguchi, Kensei
Publicado 2018

Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake

por Osumi, Hiroki, Takahari, Daisuke, Chin, Keisho, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Suzuki, Takeshi, Ota, Yumiko, Nakayama, Izuma, Ooki, Akira, Suenaga, Mitsukuni, Shinozaki, Eiji, Yamaguchi, Kensei
Publicado 2018

Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospe...

por Kitagawa, Yusuke, Osumi, Hiroki, Shinozaki, Eiji, Ota, Yumiko, Nakayama, Izuma, Suzuki, Takeshi, Wakatsuki, Takeru, Ichimura, Takashi, Ogura, Mariko, Ooki, Akira, Takahari, Daisuke, Suenaga, Mitsukuni, Chin, Keisho, Yamaguchi, Kensei
Publicado 2019

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer

por Wakatsuki, Takeru, Yamamoto, Noriko, Sano, Takeshi, Chin, Keisho, Kawachi, Hiroshi, Takahari, Daisuke, Ogura, Mariko, Ichimura, Takashi, Nakayama, Izuma, Osumi, Hiroki, Matsushima, Tomohiro, Suenaga, Mitsukuni, Shinozaki, Eiji, Hiki, Naoki, Ishikawa, Yuichi, Yamaguchi, Kensei
Publicado 2018

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer

por Yagi, Shusuke, Wakatsuki, Takeru, Yamamoto, Noriko, Chin, Keisho, Takahari, Daisuke, Ogura, Mariko, Ichimura, Takashi, Nakayama, Izuma, Osumi, Hiroki, Shinozaki, Eiji, Suenaga, Mitsukuni, Fujisaki, Junko, Ishikawa, Yuichi, Yamaguchi, Kensei, Namikawa, Ken, Horiuchi, Yusuke
Publicado 2018

A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma

por Ooki, Akira, Satoh, Taroh, Muro, Kei, Takashima, Atsuo, Kadowaki, Shigenori, Sakai, Daisuke, Ichimura, Takashi, Mitani, Seiichiro, Kudo, Toshihiro, Chin, Keisho, Kitano, Shigehisa, Thai, Dung, Zavodovskaya, Marianna, Liu, JieJane, Boku, Narikazu, Yamaguchi, Kensei
Publicado 2022

Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma:...

por Yoshikawa, Akie Kimura, Yamaguchi, Kensei, Muro, Kei, Takashima, Atsuo, Ichimura, Takashi, Sakai, Daisuke, Kadowaki, Shigenori, Chin, Keisho, Kudo, Toshihiro, Mitani, Seiichiro, Kitano, Shigehisa, Thai, Dung, Zavodovskaya, Marianna, Liu, JieJane, Boku, Narikazu, Satoh, Taroh
Publicado 2022

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer

por Osumi, Hiroki, Shinozaki, Eiji, Suenaga, Mitsukuni, Wakatsuki, Takeru, Nakayama, Izuma, Matsushima, Tomohiro, Ogura, Mariko, Ichimura, Takashi, Takahari, Daisuke, Chin, Keisho, Nagasaki, Toshiya, Konishi, Tsuyoshi, Akiyoshi, Takashi, Fujimoto, Yoshiya, Nagayama, Satoshi, Fukunaga, Yosuke, Ueno, Masashi, Yamaguchi, Kensei
Publicado 2017